GREM2 and metabolic dysfunction-associated steatotic liver disease: It has been reported that SGLT2i can decrease miRNA-34a-5p expression, which can induce downregulation of GREM2 to inactivate hepatic stellate cells of non-alcoholic fatty liver disease (39).